New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Opioids in cancer: The κ‑opioid receptor (Review)
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Opioids: classification, uses, action and dependence - MedicalVerge
Understanding opioids in veterinary medicine
κ-opioid receptor - Wikipedia
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa Receptors – Opioid Peptides
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
EX-99.2
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications